Orhub’s 9-slide deck is a lean, executive-focused presentation targeting the inefficiencies of the operating room. The company identifies a $500 billion waste problem in U.S. healthcare, proposing a software solution that translates surgical data into actionable reports for physicians and executives. The deck’s primary strength lies in its team; CEO Colt Melby is credited with leading four companies to public exchanges with a combined market cap of $1.5 billion. While the deck provides a compelling case study—citing a $1 million saving for a $100k cost at HOAG hospital—it lacks traditional ve…
Key takeaways
- The problem is defined as over $500 billion in U.S. health system waste due to antiquated systems and information overload (Slide 2).
- The solution, 'Surgical Spotlight,' integrates data from EHRs or manual systems into a real-time analytics dashboard (Slide 3).
- CEO Colt Melby brings significant public market experience, having grown Smith & Wesson from $70M to over $1BN in market cap (Slide 4).
- The company has secured $15M in financing to date as of 2019 (Slide 4).
- Product leadership includes Blake Stock, who previously managed perioperative services for over 60 hospitals (Slide 6).
- Orhub claims a strategic partnership as a Silver Microsoft Partner, providing potential access to 120 million clients (Slide 7).
- A 9x ROI is cited for reference client HOAG, generating $1M in savings for a $100K cost (Slide 8).
- The deck omits a formal 'Ask' slide, leaving the current funding requirements and terms unstated (Slide 9).
Executive Summary: The Business of Surgery
Orhub’s investor deck is a concise, 9-slide presentation that focuses on the intersection of healthcare efficiency and data analytics. The deck positions the company not just as a medical tool, but as a business solution for the 'business of surgery.' By highlighting a massive macro problem—$500 billion in waste—and countering it with a team of seasoned public-market executives, the deck attempts to build immediate credibility. However, it functions more as a teaser or a credentials deck than a full-scale fundraising vehicle, as it leaves out several critical data points regarding the business model and the specific investment opportunity.
Slide 1: Title and Vision
The cover slide features a high-resolution image of a surgical team, immediately establishing the sector. The tagline, "Revolutionizing the Business of Surgery," is a strategic choice. It signals to investors that the company is focused on the financial and operational aspects of healthcare, rather than just clinical outcomes. This distinction is important for a software-as-a-service (SaaS) play in the medical space, where the buyer is often a hospital administrator or CFO.
Slide 2: The $500 Billion Problem
Slide 2 defines the market pain point. It cites "Over $500BN of waste in the U.S. health system" and attributes this to three factors: unnecessary services, administrative costs, and antiquated systems. The slide uses a simple visual metaphor: an upward arrow for cost and downward arrows for quality of care and profitability. This slide effectively sets the stakes, though it lacks a specific source for the $500BN figure, which is a common critique of high-level problem slides.
Slide 3: The Solution - Surgical Spotlight
The solution slide introduces "Surgical Spotlight," described as powerful analytics software. The slide highlights three key features: real-time data, smart device enablement, and integration across care teams. A visual mockup shows the software running on multiple monitors and a tablet, displaying complex charts and heatmaps. The text notes that the system captures data from existing EHRs or manual systems, which addresses a major hurdle in health-tech: interoperability.
Slide 4: Leadership - Colt Melby (CEO)
This is arguably the strongest slide in the deck. Instead of a standard team slide with five tiny headshots, Orhub devotes an entire slide to its Chairman and CEO, Colt Melby. The copy highlights his 30 years of experience and a specific, impressive metric: "He's led four companies into public exchanges, combined market capitalization of $1.5BN." It lists specific growth figures for past ventures like Smith & Wesson (growing from $70M to over $1BN) and Quest Resource Holding Corp. It also notes that as of 2019, Orhub had already secured $15M in financing .
Slide 5: Medical Credibility - Dr. Robert Lazzara
Continuing the deep-dive into personnel, Slide 5 profiles the Chief Medical Director. Dr. Lazzara is presented as a pioneer in cardiac and robotic surgery. The slide mentions he is a "Smithsonian Laureate" and holds a Guinness World Record for performing a sophisticated surgery. This slide serves to validate the product’s clinical relevance, ensuring investors that the software isn't just built by 'tech people,' but is guided by a high-level practitioner.
Slide 6: Product Management - Blake Stock
The final individual profile slide features Blake Stock, the Director of Product. His credentials focus on the operational side of the hospital. With an MBA and experience as a business manager for UCSD medical center’s perioperative services, he represents the bridge between the CEO’s financial goals and the doctor’s clinical needs. The slide notes he has worked with over 60 hospitals nationwide , which suggests he understands the complexities of hospital sales cycles and implementation.
Slide 7: Strategic Partnerships
Slide 7 focuses on distribution and credibility. It identifies Orhub as a "Silver Microsoft Partner," claiming this provides access to "over 120 million clients globally." The slide also displays logos of major industry players like GE, Boston Scientific, McKesson, and Philips, under the header "Over 50 experienced representatives with informatics and medical device sales expertise." This implies a robust indirect sales channel, though it doesn't explicitly state the nature of the relationships with the other logoed companies.
Slide 8: Traction and ROI Case Study
This slide provides the necessary proof of concept. It highlights HOAG , a leading orthopedic hospital in California. The headline metric is a "9x ROI," specifically "$1M in savings for a cost of $100K." The slide is bolstered by two testimonials: one from the Executive Director of Hoag and another from the Jacksonville Jaguars Head Team Physician. These quotes emphasize that the platform is "user-friendly" and helps physicians "understand the finances of procedures."
Slide 9: Contact Information
The final slide is a standard contact page listing the CEO, Product Manager, Medical Director, and a Senior Advisor. Notably, it includes direct phone numbers and email addresses for the entire executive team, which is a high-touch approach to investor relations.
What Works in the Orhub Deck
Executive Pedigree: The decision to dedicate full slides to individual leaders is effective here because their track records are genuinely impressive. For a pre-exit or early-growth company, betting on the jockey is a common investor sentiment, and this deck leans into that. · Quantifiable ROI: The 9x ROI case study on Slide 8 is the most important business metric in the deck. In healthcare, where sales cycles are notoriously long, showing a clear path to $1M in savings is a powerful closer. · Clear Problem/Solution Fit: The deck doesn't get bogged down in the technical architecture of the software. It stays focused on the "Business of Surgery," which aligns with the interests of the hospital administrators who would buy the product and the investors who would fund it.
What is Missing from the Orhub Deck
The Ask: There is no slide detailing how much money the company is looking to raise, the valuation, or what the milestones for the next round of funding will be. · Business Model: While we know the cost to HOAG was $100k, the deck doesn't explain if this is a recurring SaaS fee, a per-case fee, or a one-time implementation cost. · Market Size (TAM/SAM/SOM): The deck mentions a $500BN waste problem, but it doesn't define the specific Addressable Market for surgical analytics software. · Competition: There is no mention of other surgical intelligence platforms or how Orhub differentiates itself from legacy EHR modules that might offer basic reporting.
Founder Lessons: What to Copy
Use Individual Team Slides for Heavy Hitters: If your team has led billion-dollar companies or holds world records, don't bury them in a grid of six headshots. Give them the space to serve as a primary reason for investment. · Focus on ROI, Not Just Features: Orhub spends very little time explaining how the data is processed and a lot of time explaining how much money it saved a specific client. This is the correct priority for a B2B pitch. · Leverage Strategic Partnerships: Mentioning a Microsoft partnership and quantifying the reach (120 million clients) helps mitigate the concern that a small startup won't be able to scale its sales force fast enough to compete.
Frequently asked questions
- What is the specific problem Orhub is trying to solve?
- According to slide 2, Orhub targets the $500 billion in waste within the U.S. healthcare system. This waste is attributed to unnecessary services, excessive administrative costs, and inefficient care delivery caused by 'antiquated systems.' The slide highlights that while data collection has increased, hospitals lack systems to manage and utilize that data effectively, leading to rising costs and falling profitability.
- How does the product actually work?
- Slide 3 describes 'Surgical Spotlight' as a powerful analytics software. It ingests data from existing Electronic Health Records (EHR) or manual systems. It then translates clinical parameters—such as surgical techniques, device implantation, and product usage—into a comprehensive, real-time dashboard accessible to care teams, physicians, and hospital executives.
- What is the track record of the leadership team?
- The deck emphasizes a high-pedigree team. CEO Colt Melby (Slide 4) has led four companies to public exchanges, including Smith & Wesson and CUI Global. Chief Medical Director Dr. Robert Lazzara (Slide 5) is a pioneer in robotic surgery and a Smithsonian Laureate. Director of Product Blake Stock (Slide 6) has experience working with over 60 hospitals nationwide on perioperative efficiency.
- Does the company have any validated traction?
- Yes, slide 8 highlights HOAG, a leading orthopedic hospital in California, as a beta and reference client. The slide claims the platform generated over $1 million in savings for a cost of $100,000, representing a 9x ROI. The deck also includes testimonials from the Executive Director of Hoag Orthopedic Institute and the Jacksonville Jaguars Head Team Physician.
- What information is missing from this pitch deck?
- The deck is missing several standard venture capital components. There is no 'Ask' slide detailing how much capital is being raised or the intended use of funds. It also lacks a competitive analysis, a detailed go-to-market strategy beyond the Microsoft partnership, and any forward-looking financial projections or unit economics.
